Zhejiang Shouxiangu Pharmaceutical Co., Ltd. is a China-based enterprise specializing in the research, development, breeding, cultivation, processing, and sale of traditional Chinese medicinal materials. Founded in 1997 and headquartered in Jinhua, Zhejiang Province, the company operates mainly in the domestic market through wholesaling and direct sales channels. Its core product portfolio includes ganoderma lucidum spore powder (broken wall and granules), ganoderma lucidum extract products, dendrobium officinale and its granules, saffron extract, crocus sativus, Tiepi Fengdou granules, and fresh dendrobium officinale. The company is recognized as a national high-tech enterprise and holds industry leadership in developing and standardizing Lingzhi and Tiepishihu medicinal products. It has contributed to the creation of ISO international standards and local provincial standards for these traditional Chinese medicines, enhancing product quality and cultivation techniques industry-wide.
In the recent 1-2 years, Zhejiang Shouxiangu Pharmaceutical has achieved significant regulatory milestones, including China registration for its ganoderma lucidum spore powder and filing certificates for related products such as broken ganoderma lucidum spore powder tablets through its wholly owned subsidiaries. These advances support its product expansion and market penetration efforts. The company maintains its strategic focus on innovation, quality control, and standardization in traditional Chinese medicine, reinforcing its position as a market leader in herbal pharmaceutical manufacturing in China.
Zhejiang Shouxiangu serves health-conscious consumers and pharmaceutical distributors, with its product lines encompassing herbal health supplements and medicinal extracts primarily used for wellness and therapeutic purposes. It leverages its extensive cultivation expertise and proprietary processing technologies to maintain product efficacy and safety. The company employs over 1,100 staff and continues to expand its influence in the healthcare and alternative medicine sectors within China, underscored by a series of product registrations and enhancements in operational capabilities.
This profile highlights Zhejiang Shouxiangu Pharmaceutical Co., Ltd.’s commitment to traditional Chinese medicine through a comprehensive range of herbal products, recent major regulatory achievements that facilitate growth, and a strategic emphasis on research and development stemming from its establishment and longstanding presence in the Chinese pharmaceutical industry. The company remains a significant player in China's ganoderma lucidum and dendrobium officinale markets, with contributions to industry standards strengthening its competitive advantage and operational excellence.
All information is accurate and reflects the latest available data as of late 2025.